China NMPA Product Recall - Tracheostomy tube

Covidien LLC, through its subsidiary Covidien Medical Devices International Trading (Shanghai) Co., Ltd., has initiated a voluntary Class I recall of specific batches of its tracheostomy cannulas. This action was reported by the National Medical Products Administration (NMPA) on May 30, 2023. The recall stems from a manufacturing error affecting connector components, which resulted in a smaller diameter than specified. This defect could lead to an insecure connection between the device connector and its protective cover, posing a potential safety risk to users. The affected products are identified under National Medical Device Registration Certificates 20172085250 and 20172085027. Covidien LLC is undertaking this recall to address the product safety issue, with detailed batch information provided in the "Medical Device Recall Event Report Form." This proactive measure, overseen by the NMPA, ensures adherence to medical device safety standards and aims to protect patient well-being by removing potentially faulty devices from circulation. The Class I designation signifies a high probability that the use of, or exposure to, the product may cause serious adverse health consequences or even death.